Dr Aung-Htut graduated with a PhD in Biochemistry and Molecular Genetics from the University of New South Wales (UNSW). Prior to her position as a senior research fellow (Co-Head of Molecular Therapy Laboratory) at the Personalised Medicine Centre, Murdoch University, she held postdoctoral positions at the UNSW and Centre for Cancer Biology, University of South Australia working on cellular aging and transcriptional regulation of programmed cell death, respectively. Her current research focuses on designing and evaluating therapeutic antisense oligonucleotides for various diseases, including multiple sclerosis, juvenile-onset Parkinson’s, and Pompe disease. Dr. Aung-Htut aims to broaden the application of these therapeutic oligonucleotides to treat both rare genetic disorders and common diseases such as cardiovascular diseases. Currently, Dr Aung-Htut and colleagues are driving towards innovative precision therapies for children with rare diseases, specifically n-of-1 approaches. She is the head of the National Critical Research Infrastructure for Accelerated ASO development, Accel_ASO.